Overview Fundamentals API Earnings EOD API Sample Code Pricing

Entrada Therapeutics Inc (TRDA NASDAQ) stock market data APIs

$14.13 -0.87(-5.8%) as of September 19, 2024
Price chart is built with Anychart

Entrada Therapeutics, Inc., a clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its EEV platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. Its therapeutic candidates, which include ENTR-601-44, which is in Phase I clinical trial for the treatment of Duchenne muscular dystrophy; and ENTR-701, which is in Phase 1/2 clinical trial for the treatment of myotonic dystrophy type 1. The company also offers ENTR-601-45 and ENTR-601-50, which are in preclinical trail for the treatment of Duchenne muscular dystrophy; and ENTR-501, an intracellular thymidine phosphorylase enzyme replacement therapy, which is in preclinical trail for the treatment of mitochondrial neurogastrointestinal encephalomyopathy. Entrada Therapeutics, Inc. has a strategic collaboration and license agreement with Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize ENTR-701. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Entrada Therapeutics Inc Financial Data Overview

15
14.13
-
15.38
14.085
10.75-18.17
558 M
4.9669
37 200 K
239 M
1.5499
-0.239
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'TRDA',
Type: 'Common Stock',
Name: 'Entrada Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00MTSMC16',
ISIN: NULL,
CUSIP: NULL,
CIK: '1689375',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-10-29',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Entrada Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 239 M
  • EBITDA 96 867 K
  • Earnings Per Share 3.02
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Entrada Therapeutics Inc Earnings via APIs

  • Latest Release 2024-08-06
  • EPS/Forecast 0.14

Get Entrada Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com